Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [524]

Encorafenib/binimetinib/nivolumab combo improves PFS in BRAF-mutant melanoma...

Dr Zeynep Eroglu - Moffitt Cancer Center, Tampa, USA

Encorafenib/binimetinib/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases ( Dr Zeynep Eroglu - Moffitt Cancer Center, Tampa, USA )

Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in...

Dr Ahmad Tarhini - Moffitt Cancer Center, Tampa, USA

Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resectable melanoma ( Dr Ahmad Tarhini - Moffitt Cancer Center, Tampa, USA )

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous...

Dr Danny Rischin - Peter MacCallum Cancer Centre, Melbourne, Australia

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma ( Dr Danny Rischin - Peter MacCallum Cancer Centre, Melbourne, Australia )

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for...

Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center...

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for BRAF-positive advanced melanoma ( Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma

Dr Milad Ibrahim - NYU Langone Health, New York, USA

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma ( Dr Milad Ibrahim - NYU Langone Health, New York, USA )

Understanding Uganda's drug safety regulations

Dr Kennedy Odokonyero - PHV LATAM/IntuVigilance, Kampala, Uganda

Understanding Uganda's drug safety regulations ( Dr Kennedy Odokonyero - PHV LATAM/IntuVigilance, Kampala, Uganda )

Understanding the role of the Tanzania Medicines and Medical Devices Authority

Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma...

Understanding the role of the Tanzania Medicines and Medical Devices Authority ( Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania )

Expectations and priorities of older patients with cancer: the PRIORITY...

Dr Camille Chakiba - Institute Bergonié, Bordeaux, France

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study ( Dr Camille Chakiba - Institute Bergonié, Bordeaux, France )

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable...

Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma ( Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands )

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Association of adult attachment with delays in accessing specialist care in...

Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

More from ecancer